跳至主要内容
临床试验/NCT01283412
NCT01283412Unknown3 期

Intraoperative Application of Dexmedetomidine on the Incidence of Postoperative Delirium and Quality of Recovery in Geriatric Patients Undergoing Major Surgery

Huazhong University of Science and Technology1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
500
试验地点
1
主要终点
Postoperative delirium

研究概览

简要总结

Postoperative agitation (hyperactive delirium) is common following major surgery(incidence was about 20% in our pilot study). Dexmedetomidine was related to a reduced delirium rate when comparing with midazolam in many clinical settings. It is not clear if dexmedetomidine is useful on reducing postoperative delirium. The hypothesis of present study: intraoperative application of dexmedetomidine (0.2ug/kg/h) is is effective (50% reduce) than placebo for reducing of early postoperative delirium and increase postoperative quality of recovery within 24 postoperative hours.

详细描述

After approval from the Institute's Ethics Committee, this study was conducted at Tongji Hospital, a general university teaching hospital with 2500 beds in Wuhan, China.The study consisted of adult patients, American Society of Anaesthesiologists Physical Status (ASA-PS) I-III, undergoing selective major surgery under general anesthesia. All the patients were randomly assigned to receive dexmedetomidine or placebo during the operation. The primary outcome measure was postoperative delirium assessed by Nursing Delirium Screening Scale (Nu-DESC) every 8 hours within 24 postoperative hours. The secondary outcome was length of postanesthesia care unit (PACU) stay,postoperative hospital length of stay, hemodynamic parameters, the incidence of postoperative nausea and vomiting, and quality of recovery determined by quality of recovery (QOR40; maximum score 200)and Post-operative Quality Recovery Scale (PQRS) in the first 24 h after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA physical status class I-III
  • Aged 60 years or above
  • Elective major surgery under general anesthesia

排除标准

  • ASA-PS>=IV
  • Aged under 60 yr old
  • Body mass index (BMI) >30
  • Neurologic disease
  • Cardiac surgery and neurologic surgery
  • Anticonvulsant drugs
  • Chronic analgesics intake
  • Participating in the investigation of another study

研究组 & 干预措施

Arm P

Active Comparator

Placebo infusion

干预措施: Placebo (Drug)

Arm D

Experimental

Dexmedetomidine infusion

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Postoperative delirium

时间窗: every 8 hours within 24 postoperative hours

Postoperative delirium was determined by Nu-DESC every 8 hours within 24 postoperative hours

次要结局

  • quality of recovery determined by QOR40 and Postoperative Quality Recovery Scale (PQRS)(24 postoperative hours)
  • Postoperative Stroke(1st, 2nd, 3rd, 7th postoperative days)
  • Length of PACU stay(during PACU stay)
  • hemodynamic parameters(every 5min during operation and every 15min during PACU stay)
  • Postoperative delirium(1st, 2nd, 3rd postoperative days)
  • incidence of postoperative nausea and vomiting(24 postoperative hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Mei

Associate Professor

Huazhong University of Science and Technology

研究点 (1)

Loading locations...

相似试验

Dexmedetomidine on Postoperative Delirium and... | 临床试验